Caribou Biosciences (CRBU) Non-Current Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Non-Current Assets data on file, last reported at $26.6 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $26.6 million, down 52.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $124.6 million (down 65.31% YoY), and the FY2025 annual result was $30.1 million, down 67.92% from the prior year.
• Non-Current Assets fell to $26.6 million in Q1 2026 per CRBU's latest filing, from $30.1 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $113.5 million in Q4 2022 and troughed at $26.6 million in Q1 2026.
• A 5-year average of $78.1 million and a median of $91.9 million in 2022 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 611.69% in 2022, then slumped 72.18% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $113.5 million in 2022, then fell by 17.75% to $93.4 million in 2023, then increased by 0.61% to $93.9 million in 2024, then sank by 67.92% to $30.1 million in 2025, then declined by 11.67% to $26.6 million in 2026.
• Business Quant data shows CRBU's Non-Current Assets at $26.6 million in Q1 2026, $30.1 million in Q4 2025, and $39.5 million in Q3 2025.